2026-07-282026-07-272026-07-242026-07-232026-07-222026-07-212026-07-202026-07-172026-07-162026-07-152026-07-142026-07-102026-06-292026-06-192026-06-182026-06-172026-06-162026-06-152026-06-122026-06-112026-06-102026-06-092026-06-082026-06-052026-06-042026-06-032026-06-022026-06-012026-05-302026-05-292026-05-282026-05-272026-05-252026-05-222026-05-212026-05-202026-05-192026-05-182026-05-152026-05-11
Stock-market dispatch — 2026-07-24
Headless run (Fri). Research output, not advice — brain never trades. Marks are live 07-24 intraday
twelvedataquotes (markets open); 42/42 symbols priced, 0 429s (api.twelvedata.com reachable). Supabase sync + push are performed by the wrapper, not this run.
Top of mind
Intel's 7th straight beat is the wrong kind of beat for the foundry thesis, and the market said so. INTC Q2 printed rev $16.1B (+25% YoY, strongest growth in 15+ yrs), EPS $0.42 vs $0.20, DCAI +59% — a decisive internal-execution beat — yet raised FY26 capex to >$20B while naming zero external 18A/14A customer under repeated analyst pressure (Arya, Reitzes, Muse). Same-day autoresearch confirms: the one fresh name (Fortinet, 07-21) is Intel-4, not leading-edge; 14A is still "two unnamed prospects." So the tsmc-saturation-to-intel-anchor-stack Step-4 external-anchor leg stays partial — capex is running far ahead of any disclosed external PO (external foundry rev ~$293M), and the new falsifier is: if capex keeps rising while external revenue stays ~$0.3B/qtr, "speculative build" beats "anchor-customer." Stock −2.3% ($100.23). The genuinely-useful read is the by-product: CFO Zinsner's "most severe supply constraints in [industry] history across leading-edge logic, wafers, memory, substrates" independently corroborates hbm-cowos-as-binding-bottleneck and memory-shock-to-oem-value-transfer from a first-party source. Separately, UNP Q2 beat-and-raise (rev $6.9B +12%, EPS $3.41, OR 59.2%, guide raised) rewarded +4.0% and disclosed a CN merger-settlement + STB supplemental (~07-27) — proactive remedies that raise approval odds but cap pricing upside.
Strongest-conviction buys
Ranked shortlist (4c). Prices 07-24 intraday, twelvedata.
| # | Ticker | Causal chain (mechanism) | Conviction | Valuation vs base | Fundamentals (one line) | Next catalyst |
|---|---|---|---|---|---|---|
| 1 | MU | hbm-cowos-as-binding-bottleneck | High (0.80) | Yes — $990.21 (+3.2%, −21% off hi) | ~6× fwd, HBM booked thru CY2027; INTC + SemiAnalysis both corroborate binding memory constraint | HBM4 ramp / SK Hynix reads |
| 2 | CCJ | ai-capex-to-power-and-materials-cascade + kazatomprom-supply-cut-to-western-uranium-premium | Med-high (0.73) | Yes — $89.33 (−1.2%, −34% off hi) | Live −20.6% abs but only −1.6% sector (theme de-rated, pick held) | Utility contracting |
| 3 | TSM | hbm-cowos-as-binding-bottleneck | Med-high (0.70) | At base — $415.58 (−1.3%, −13% off hi) | 18–19× fwd; CoWoS booked thru 2027 | N2 ramp |
| 4 | NOW | agentic-ai-seat-erosion-to-saas-rerate | Med-high (0.62) | Yes — $91.95 (−3.7%, −56% off hi) | Q2 beat+raise, falsifier didn't fire; base $140–150 (~+50%) | Q3 print; ACV conversion |
| 5 | EQT | ai-gas-demand-to-appalachian-producer-price-floor | Medium (0.55) | Marginal — $53.39 (−1.1%, −22% off hi) | Net debt $5.5B (↓$7.7B), FCF+, FY vol guide raised | 2028–30 demand step; EIA STEO |
⚠ LIN (high, 0.78) stays off the buy list — $506.32, −8% off high, "through target." Watchlist. LLY (med-high 0.60) marginal on valuation → watchlist.
Watchlist
| Ticker | Thesis | Conviction | Price | Undervalued vs base? | Next catalyst |
|---|---|---|---|---|---|
| MU | hbm-cowos-as-binding-bottleneck | High | $990.21 (+3.2%) | Yes | HBM4 ramp |
| CCJ | kazatomprom-supply-cut-to-western-uranium-premium | Med-high | $89.33 | Yes | Contracting |
| TSM | hbm-cowos-as-binding-bottleneck | Med-high | $415.58 | At base | N2 ramp |
| NOW | agentic-ai-seat-erosion-to-saas-rerate | Med-high | $91.95 (−3.7%) | Yes | Q3 print |
| UNP | up-nsc-transcontinental-merger-to-pricing-power | Low (0.42) | $304.33 (+4.0%) | No (ran on beat) | STB supplemental ~07-27 |
| CME | rate-uncertainty-to-cme-futures-volume-toll | Low (0.42) | $254.32 (+2.0%) | Marginal | Q2 ADV print |
| INTC | tsmc-saturation-to-intel-anchor-stack | Medium | $100.23 (−2.3%) | ⚠ external-anchor unproven | 14A firm decisions H2'26→H1'27 |
| MP | china-ree-controls-to-us-producer-stack | Medium | $44.65 (near 52w low) | Yes | Nov 10 deadline |
Undervalued candidates (today)
- agentic-ai-seat-erosion-to-saas-rerate — NOW $91.95, −56% off high, still bleeding two days after a beat-and-raise that de-risked the mechanism (falsifier didn't fire). Sharpest undervalued-vs-base divergence in the book.
- china-ree-controls-to-us-producer-stack — MP $44.65, essentially at its 52w low ($43.71), into the Nov 10 China REE deadline; Gromen corroborates REE constriction is continuing.
New chains to investigate (hypothesis-stage)
- rail-duopoly-endgame-to-csx-consolidation-rerate — CSX (prospect-chains, thin transport vertical, 2nd-order). The UNP–NS merger + CPKC-Creel's cited "duopoly triggering further consolidation" warning imply BNSF must seek an eastern counter-network → CSX is the forced counter-merger target. To graduate: a BNSF/Berkshire signal of eastern-Class-I appetite + STB language enabling a second transcontinental (steps 3-4 ⚠ unverified). → /explore-chain.
New theses (now active)
- rate-uncertainty-to-cme-futures-volume-toll — CME, conviction low (0.42). Breadth-steered net-new in the thin financials/rate-regime cluster: the two-sided Warsh Fed (9-9 FOMC split; implied hike-odds 18%→36% in 11 days) drives record CME STIR open interest → CME clips a per-contract toll regardless of direction — orthogonal to the crowded NIM/float longs. Weak link: OI≠ADV (confirm at Q2 print). Also created federated-hermes (FHI, MMF-stickiness leg).
Updated theses (existing active)
- tsmc-saturation-to-intel-anchor-stack — INTC Q2 confirmed the internal-execution beat but not the external-foundry proof point. Step-4 external-anchor leg held
partial; new "speculative build" falsifier added.as_of→07-24. - up-nsc-transcontinental-merger-to-pricing-power — Q2 actuals: standalone accretion confirmed (OR 59.2% held through fuel headwind); CN settlement + voluntary commitments raise approval odds, cap upside.
as_of→07-24. - helium-cliff-to-hbm-supply-crunch — +new data point: China helium export ban (Gromen, MacroVoices) despite floor prices — a second geopolitical chokepoint on the HBM/packaging input.
as_of→07-24. - china-ree-controls-to-us-producer-stack — Gromen corroborates continuing REE constriction / trade-agreement non-compliance.
as_of→07-24.
Contradicted / weakened
- No active thesis falsified today; 0 calibrations filed. (INTC's beat strengthened the internal/supply legs; the external-anchor leg was already
partial, not newly broken.)
Open questions worth a human's eye
- INTC: how many marks does a beating-but-unproven foundry thesis get? The print was internally excellent yet externally unproven; INTC is −21% inception sector-excess (medium-tier, so no 4e gate) and flagged for exit-review since 06-18. Is the trade the problem, not the thesis?
- The 4e calibration gate never fires (7th consecutive mark). All three < −10% sector flags (PWR −12.6%, UUUU −11.1%, TJX −10.1%) are
medium; 4e only reads high/med-high. The med-high names (CCJ −1.6%, TSM −3.3%) are not the laggards — mildly reassuring on label calibration, but the gate remains structurally silent. - CME uncertainty-toll: OI records ≠ transaction revenue. Confirm CME's Q2/July rate-complex ADV before sizing the new chain.
What I looked at
- Run status: headless; steps 0.5–7 in-turn; price fetch paced 8/min — 42/42 priced (SSNLF OTC excluded, +FHI/EXE added), 0 429s. PAPER-LEDGER weekly mark (4d) due & recorded on the live-digest basis; the inception-dated hypothetical re-mark was deferred (headless budget), not fabricated.
- Breadth (2a): ai-infrastructure 49% ⚠ over → net-new steered to thin verticals: financials/rate-regime (CME mechanism + FHI) and transport (CSX hypothesis). No new AI-infra beneficiary drafted.
- Ingestion veins (0.5–0.7): podcast 2 (MacroVoices/Gromen — corroboration across helium/REE/defense/gold; Compound&Friends/Ron Baron — SpaceX sentiment, zero-novelty); earnings 2 (INTC Q2, UNP Q2 — both ⚠ partial; SLB call 07-24 not yet published → next run; HON not pulled); feeds 0 (SemiAnalysis Vera Rubin already ingested 07-23; Construction Physics 07-23 cost-essay off-topic/no-ticker; FabKnowledge/Apricitas nothing new).
- Steps 1–2b: 2 autoresearch (INTC foundry-customer gap → confirmed no named leading-edge customer; financials/rate-regime → CME uncertainty-toll). prospect-chains: 1 auto-drafted (rail-duopoly-endgame-to-csx-consolidation-rerate, CSX).
- Sources: 6 promoted + 6 ingested → 3 created (rate-uncertainty-to-cme-futures-volume-toll mechanism, federated-hermes, david-zinsner), 10+ updated (intel / union-pacific / cme-group entities; up-nsc / intel-anchor / helium / REE mechanisms; luke-gromen +5, lip-bu-tan +3, jim-vena/jennifer-hamann/ron-baron persons), 3 zero-novelty (UNP-confirmation, Gromen-new-pages, Ron Baron), 0 contradictions. 4 stale off-topic clippings left in inbox.
- Live feedback (4e): 23 rows, 3 flags < −10% sector (PWR −12.6%, UUUU −11.1%, TJX −10.1%), all
medium→ 0 auto-calibrations (7th consec). Best: CF/CBAM +9.5%, DNN +11.7% sector. - Signal feed (7): full active/armed set — see below. +1 net-new row (CME). Prices re-marked 07-24;
as_ofre-dated only for mechanisms that moved a step today (intel-anchor, up-nsc, helium, REE, + the new CME row); others carried forward. Supabase sync performed by the wrapper, not this run.